Clinical trial
A Rapid Onset and Short Duration Insulin Secretogogue, Mitiglinide, in Combination With Metformin Versus Metformin Alone in Patients With Type 2 Diabetes Mellitus: A Randomized, Double-blind, Placebo-controlled Trial for 6 Months
NCT00519142 is registered in ClinicalTrials.gov with Elixir Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Rapid Onset and Short Duration Insulin Secretogogue, Mitiglinide, in Combination With Metformin Versus Metformin Alone in Patients With Type 2 Diabetes Mellitus: A Randomized, Double-blind, Placebo-controlled Trial for 6 Months
- Lead sponsor
- Elixir Pharmaceuticals
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- August 31, 2007
- Completion date
- October 31, 2008
- Enrollment
- 367 (actual)
- Sites
- 61
Conditions
As the registry lists them; a condition with its own page is linked.